Analysis reveals significant mortality disparities in classical Hodgkin lymphoma by race and ethnicity, indicating important implications for cancer care.
Key Points
Significantly higher all-cause mortality is observed among non-Hispanic Black patients compared to non-Hispanic White patients.
Cumulative mortality after 10 years was highest among American Indian/Alaska Native patients at about 33%.
Multivariable models estimated hazard ratios for various racial and ethnic groups, adjusting for key characteristics.
Findings underscore the need to address disparities in cancer survival and improve care for diverse populations.